Literature DB >> 11163093

Induction of T-cell response to cryptic MHC determinants during allograft rejection.

F Boisgérault1, N G Anosova, R C Tam, B M Illigens, E V Fedoseyeva, G Benichou.   

Abstract

The presentation of MHC peptides by recipient and donor antigen presenting cells is an essential element in allorecognition and allograft rejection. MHC proteins contains two sets of determinants: the dominant determinants that are efficiently processed and presented to T cells, and the cryptic determinants that are not presented sufficiently enough to induce T-cell responses in vivo. In transplanted mice, initial T-cell response to MHC peptides is consistently limited to a single or a few immunodominant determinants on donor MHC molecule. However, in this article we show that under appropriate circumstances the hierarchy of determinants on MHC molecules can be disrupted. First, we observed that gamma IFN can trigger de novo presentation of cryptic self-MHC peptides by spleen cells. Moreover, we showed that allotransplantation is associated with induction of T-cell responses to formerly cryptic determinants on both syngeneic and allogeneic MHC molecules. Our results suggest that cross-reactivity and inflammation are responsible for the initiation of these auto- and alloimmune responses after transplantation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163093     DOI: 10.1016/s0198-8859(00)00209-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

Review 1.  Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance.

Authors:  Jose M M Granados; Gilles Benichou; Tatsuo Kawai
Journal:  Curr Opin Organ Transplant       Date:  2015-02       Impact factor: 2.640

Review 2.  Monitoring alloimmune response in kidney transplantation.

Authors:  Oriol Bestard; Paolo Cravedi
Journal:  J Nephrol       Date:  2016-05-31       Impact factor: 3.902

Review 3.  Immune recognition and rejection of allogeneic skin grafts.

Authors:  Gilles Benichou; Yohei Yamada; Seok-Hyun Yun; Charles Lin; Michael Fray; Georges Tocco
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

Review 4.  Natural killer cells in rejection and tolerance of solid organ allografts.

Authors:  Gilles Benichou; Yohei Yamada; Akihiro Aoyama; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

5.  The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.

Authors:  M J Weiss; D A Guenther; J D Mezrich; H Sahara; C Y Ng; A J Meltzer; J K Sayre; M E Cochrane; A C Pujara; S L Houser; D H Sachs; B R Rosengard; J S Allan; G Benichou; J C Madsen
Journal:  Am J Transplant       Date:  2009-01       Impact factor: 8.086

Review 6.  Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.

Authors:  Jeanne Menez-Jamet; Catherine Gallou; Aude Rougeot; Kostas Kosmatopoulos
Journal:  Ann Transl Med       Date:  2016-07

7.  Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants.

Authors:  Ben M Illigens; Akira Yamada; Natalie Anosova; Victor M Dong; Mohamed H Sayegh; Gilles Benichou
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

8.  Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection.

Authors:  Sangho Lim; Nancy C Kirkiles-Smith; Jordan S Pober; Alfred L M Bothwell; Je-Min Choi
Journal:  Biomaterials       Date:  2018-08-21       Impact factor: 12.479

Review 9.  Allorecognition by T Lymphocytes and Allograft Rejection.

Authors:  Jose Marino; Joshua Paster; Gilles Benichou
Journal:  Front Immunol       Date:  2016-12-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.